LifeTech Scientific Corporation (HKG:1302)
Hong Kong · Delayed Price · Currency is HKD
1.590
+0.010 (0.63%)
At close: Mar 4, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Structural Heart Diseases Business | 527.58M | 495.67M | 394.57M | 331.06M | 297.10M | | | | | |
Structural Heart Diseases Business Growth | 6.44% | 25.62% | 19.19% | 11.43% | -16.94% | | | | | |
Peripheral Vascular Diseases Business | 751.11M | 707.11M | 644.34M | 548.53M | 430.57M | | | | | |
Peripheral Vascular Diseases Business Growth | 6.22% | 9.74% | 17.47% | 27.40% | 8.53% | | | | | |
Cardiac Pacing and Electrophysiology Business | 25.01M | 64.40M | 58.39M | 45.74M | 25.97M | | | | | |
Cardiac Pacing and Electrophysiology Business Growth | -61.17% | 10.29% | 27.65% | 76.16% | 7.56% | | | | | |
| - | - | - | - | -111.35M | | | | | |
| 1.30B | 1.27B | 1.10B | 925.33M | 642.30M | | | | | |
| 2.88% | 15.48% | 18.59% | 44.07% | -3.97% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 957.11M | 992.13M | 895.05M | 774.04M | 538.95M | | | | | |
| -3.53% | 10.85% | 15.63% | 43.62% | 6.97% | | | | | |
Asia ( Excluding China’s mainland ) | 98.50M | 67.42M | 50.79M | 31.83M | 17.13M | | | | | |
Asia ( Excluding China’s mainland ) Growth | 46.10% | 32.75% | 59.57% | 85.86% | -58.31% | | | | | |
| 131.75M | 111.09M | 72.66M | 68.26M | 57.68M | | | | | |
| 18.60% | 52.88% | 6.45% | 18.34% | -17.95% | | | | | |
| 53.57M | 46.40M | 34.69M | 20.23M | 11.07M | | | | | |
| 15.44% | 33.76% | 71.47% | 82.77% | -59.61% | | | | | |
| 36.07M | 33.53M | 29.95M | 21.14M | 13.40M | | | | | |
| 7.55% | 11.96% | 41.68% | 57.79% | -33.22% | | | | | |
| 18.93M | 11.27M | 8.55M | 7.15M | 3.15M | | | | | |
| 67.93% | 31.92% | 19.52% | 126.91% | 5.21% | | | | | |
| 7.78M | 5.33M | 5.62M | 2.69M | 925.00K | | | | | |
| 45.98% | -5.18% | 108.89% | 190.70% | -71.05% | | | | | |
| 1.30B | 1.27B | 1.10B | 925.33M | 642.30M | | | | | |
| 2.88% | 15.48% | 18.59% | 44.07% | -3.97% | | | | | |
Source: S&P Global Market Intelligence.